I mentioned in my post on Wednesday about the dire situation in Switzerland and suggested that msb partner with Roche.
I meant Novartis
There is a massive swiss market for rem-l and we are now partnering with one company that must have influence. Very significant announcement.
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-127
-
- There are more pages in this discussion • 685 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.010(0.68%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.45 | $1.627M | 1.100M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10500 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 13082 | 4 |
View Market Depth
| Last trade - 10.45am 12/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |